Fidson Healthcare

Fidson Healthcare FCF Yield

The Free Cash Flow Yield of Fidson Healthcare (FIDSON.NL) as of Oct 31, 2026 is -1.95 %. In the previous year, Free Cash Flow Yield was -1.33 % — a change of 46.69% (lower).

FCF Yield

-1.95 %

YoY

46.69%

Last updated:

Free Cash Flow Yield of Fidson Healthcare is 2024 -1.95 % . Free Cash Flow Yield of Fidson Healthcare was 2023 -1.33 % . It decreases by 46.69% lower compared to the previous year.

The Fidson Healthcare FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2017
0.60 NGN
Jan 1, 2018
-0.79 NGN
Jan 1, 2019
-0.34 NGN
Jan 1, 2020
0.35 NGN
Jan 1, 2021
2.00 NGN
Jan 1, 2022
-0.52 NGN
Jan 1, 2023
-1.33 NGN
Jan 1, 2024
-1.95 NGN
The Fidson Healthcare FCF Yield history
YEARFCF YieldYoY
-1.95 %+46.69%
-1.33 %+158.18%
-0.52 %-125.86%
2.00 %+471.30%
0.35 %-202.07%
-0.34 %-56.78%
-0.79 %-232.45%
0.60 %-3.18%
0.62 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fidson Healthcare Stock analysis

What does Fidson Healthcare do? Fidson Healthcare Plc manufactures and distributes pharmaceutical products, including drugs, infusion and injectables, across its segments: over-the-counter, ethical products, and consumer. The over-the-counter segment sells products directly to consumers without prescriptions, while the ethical products segment offers prescription-only drugs, injectables, and infusions. The consumer segment focuses on household items. The company provides formulation/development, contract manufacturing, and production services for medicines. Its product portfolio includes Anti Infective & Anti Malaria, Central Nervous System (CNS), Gastrointestinal Medicines, Supplements, Topical/Dermatological Medicines, Vitamins & Minerals, Ophthalmic Solution, and others, with Ophthalmic Solution specifically targeting eye conditions. The company's primary revenue streams come from the sale of pharmaceutical products within its three segments. Over-the-counter products are purchased by general consumers, ethical products are bought by healthcare providers and pharmacies requiring prescriptions, and consumer segment items are sold to households. Fidson Healthcare Plc serves the Nigerian market through its manufacturing and distribution network, leveraging its full-time workforce of 593 employees to support operations. Fidson Healthcare Plc's product lines are tailored to specific market needs, with Anti Infective & Anti Malaria products addressing infectious diseases, CNS medications targeting neurological disorders, and Ophthalmic Solution treating eye conditions. The company's services in formulation/development and contract manufacturing further generate revenue by supporting other pharmaceutical firms in product creation and production. Fidson Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fidson Healthcare stock

Free Cash Flow Yield of Fidson Healthcare is -1.95 % in 2024.

Free Cash Flow Yield of Fidson Healthcare changed from -1.33 % to -1.95 %, representing a 46.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Fidson Healthcare since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Fidson Healthcare with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Fidson Healthcare

All Key Metrics — Fidson Healthcare